title: Progesterone-dependent immunomodulation.
abstract: The biological effects of progesterone are mediated by a 34-kDa protein named the progesterone-induced blocking factor (PIBF). PIBF, synthesized by lymphocytes of healthy pregnant women in the presence of progesterone, inhibits arachidonic acid release as well as NK activity, and modifies the cytokine balance. Within the cell the full-length PIBF is associated with the centrosome, while secretion of shorter forms is induced by activation of the cell. PIBF induces nuclear translocation of STAT6 as well as PKC phosphorylation and exerts a negative effect on STAT4 phosphorylation. The concentration of PIBF in pregnancy urine is related to the positive or negative outcome of pregnancy; furthermore, premature pregnancy termination is predictable by lower than normal pregnancy PIBF values. In vivo data suggest the biological importance of the above findings. Treatment of pregnant Balb/c mice with the antiprogesterone RU 486 results in an increased resorption rate, which is associated with the inability of spleen cells to produce PIBF. High resorption rates induced by progesterone receptor block as well as those due to high NK activity are corrected by simultaneous PIBF treatment.
authors.affiliation: Department of Medical Microbiology and Immunology, Pecs University, Medical School, Pecs, Hungary.
authors.forename: J
authors.initials: J
authors.lastname: Szekeres-Bartho
authors.forename: B
authors.initials: B
authors.lastname: Polgar
authors.forename: N
authors.initials: N
authors.lastname: Kozma
authors.forename: E
authors.initials: E
authors.lastname: Miko
authors.forename: G
authors.initials: G
authors.lastname: Par
authors.forename: L
authors.initials: L
authors.lastname: Szereday
authors.forename: A
authors.initials: A
authors.lastname: Barakonyi
authors.forename: T
authors.initials: T
authors.lastname: Palkovics
authors.forename: O
authors.initials: O
authors.lastname: Papp
authors.forename: P
authors.initials: P
authors.lastname: Varga
mesh_terms: D000021:Abortifacient Agents, Steroidal / Q000494:pharmacology; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000378:metabolism*; D007694:Killer Cells, Natural / Q000276:immunology; D051379:Mice; D015735:Mifepristone / Q000494:pharmacology; D011247:Pregnancy; D011256:Pregnancy Outcome; D011257:Pregnancy Proteins / Q000276:immunology / Q000652:urine; D011374:Progesterone / Q000276:immunology*; D015398:Signal Transduction; D013491:Suppressor Factors, Immunologic / Q000652:urine
chemical_list: D000021:Abortifacient Agents, Steroidal; D016207:Cytokines; D007155:Immunologic Factors; C110058:PIBF1 protein, human; C491677:Pibf1 protein, mouse; D011257:Pregnancy Proteins; D013491:Suppressor Factors, Immunologic; D015735:Mifepristone; D011374:Progesterone